Search Results

There are 68368 results for: content related to: Correlates of PDE5i Use among Subjects with Erectile Dysfunction in Two Population-Based Surveys

  1. Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 2: Updates on Optimal Utilization for Sexual Concerns and Rare Toxicities in This Class (CME)

    The Journal of Sexual Medicine

    Volume 6, Issue 9, September 2009, Pages: 2352–2364, Alan W. Shindel

    Version of Record online : 26 AUG 2009, DOI: 10.1111/j.1743-6109.2009.01447.x

  2. Profiling Characteristics of Men Who Use Phosphodiesterase Type 5 Inhibitors Based on Obtaining Patterns: Data from the Nationwide Japanese Population

    The Journal of Sexual Medicine

    Volume 9, Issue 6, June 2012, Pages: 1649–1658, Masaki Kimura, Satoru Shimura, Hideyuki Kobayashi, Toshihiro Tai, Yutaka Chikano, Shiro Baba, Munehide Kano and Koichi Nagao

    Version of Record online : 18 APR 2012, DOI: 10.1111/j.1743-6109.2012.02728.x

  3. Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve-sparing radical prostatectomy: a systematic review of placebo-controlled randomized trials with trial sequential analysis

    Andrology

    E. Limoncin, G. L. Gravina, G. Corona, M. Maggi, G. Ciocca, A. Lenzi and E. A. Jannini

    Version of Record online : 8 AUG 2017, DOI: 10.1111/andr.12403

  4. Proceedings of the 20th Annual Fall Scientific Meeting of the Sexual Medicine Society of North America, Miami Beach, USA, November 20–23, 2014

    The Journal of Sexual Medicine

    Volume 12, Issue S2, May 2015, Pages: 101–183,

    Version of Record online : 9 APR 2015, DOI: 10.1111/jsm.12808

  5. Recreational Use of Phosphodiesterase Type 5 Inhibitors by Healthy Young Men

    The Journal of Sexual Medicine

    Volume 7, Issue 11, November 2010, Pages: 3736–3742, Amado Bechara, Adolfo Casabé, Walter De Bonis, Adrián Helien and María Victoria Bertolino

    Version of Record online : 16 AUG 2010, DOI: 10.1111/j.1743-6109.2010.01965.x

  6. You have free access to this content
    Phosphodiesterase type 5 inhibitors for erectile dysfunction

    BJU International

    Volume 96, Issue 3, August 2005, Pages: 257–280, Culley C. Carson and Tom F. Lue

    Version of Record online : 24 JUL 2005, DOI: 10.1111/j.1464-410X.2005.05614.x

  7. You have free access to this content
    Acute Nonarteritic Anterior Ischemic Optic Neuropathy and Exposure to Phosphodiesterase Type 5 Inhibitors

    The Journal of Sexual Medicine

    Volume 12, Issue 1, January 2015, Pages: 139–151, Ulka B. Campbell, Alexander M. Walker, Michael Gaffney, Kenneth R. Petronis, Dana Creanga, Sheila Quinn, Barbara E.K. Klein, Alan M. Laties, Michael Lewis, Ira D. Sharlip, Francesca Kolitsopoulos, Brian J. Klee, Jingping Mo and Robert F. Reynolds

    Version of Record online : 31 OCT 2014, DOI: 10.1111/jsm.12726

  8. Proceedings of the 17th Annual Congress of the European Society for Sexual Medicine, Copenhagen, Denmark, February 5–7, 2015

    The Journal of Sexual Medicine

    Volume 12, Issue S3, May 2015, Pages: 188–271,

    Version of Record online : 9 APR 2015, DOI: 10.1111/jsm.12872_2

  9. Continuing Medical Education: 2009 Update on Phosphodiesterase Type 5 Inhibitor Therapy Part 1: Recent Studies on Routine Dosing for Penile Rehabilitation, Lower Urinary Tract Symptoms, and Other Indications (CME)

    The Journal of Sexual Medicine

    Volume 6, Issue 7, July 2009, Pages: 1794–1808, Alan W. Shindel

    Version of Record online : 24 JUN 2009, DOI: 10.1111/j.1743-6109.2009.01347.x

  10. Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction

    International Journal of Gynecology & Obstetrics

    Volume 133, Issue 2, May 2016, Pages: 139–145, Liang Gao, Lu Yang, Shengqiang Qian, Tao Li, Ping Han and Jiuhong Yuan

    Version of Record online : 17 DEC 2015, DOI: 10.1016/j.ijgo.2015.08.015

  11. Testosterone/Estradiol Ratio Regulates NO-Induced Bladder Relaxation and Responsiveness to PDE5 Inhibitors

    The Journal of Sexual Medicine

    Volume 9, Issue 12, December 2012, Pages: 3028–3040, Linda Vignozzi, Sandra Filippi, Annamaria Morelli, Paolo Comeglio, Ilaria Cellai, Erica Sarchielli, Elena Maneschi, Rosa Mancina, Mauro Gacci, Gabriella Barbara Vannelli and Mario Maggi

    Version of Record online : 11 OCT 2012, DOI: 10.1111/j.1743-6109.2012.02946.x

  12. You have free access to this content
    Genomic origin and transcriptional regulation of two variants of cGMP-binding cGMP-specific phosphodiesterases

    European Journal of Biochemistry

    Volume 262, Issue 3, June 1999, Pages: 866–873, Jun Kotera, Kotomi Fujishige, Yuji Imai, Eri Kawai, Hideo Michibata, Hiroyuki Akatsuka, Noriyuki Yanaka and Kenji Omori

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1432-1327.1999.00450.x

  13. Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro

    The Journal of Sexual Medicine

    Volume 8, Issue 3, March 2011, Pages: 696–704, Antonio Aversa, Massimiliano Caprio, Antonella Antelmi, Andrea Armani, Marina Brama, Emanuela A. Greco, Davide Francomano, Matilde Calanchini, Giovanni Spera, Luigi Di Luigi, Giuseppe M.C. Rosano, Andrea Lenzi, Silvia Migliaccio and Andrea Fabbri

    Version of Record online : 22 DEC 2010, DOI: 10.1111/j.1743-6109.2010.02152.x

  14. Serum testosterone, testosterone replacement therapy and all-cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins

    International Journal of Clinical Practice

    Volume 70, Issue 3, March 2016, Pages: 244–253, G. Hackett, A. H. Heald, A. Sinclair, P. W. Jones, R. C. Strange and S. Ramachandran

    Version of Record online : 24 FEB 2016, DOI: 10.1111/ijcp.12779

  15. The Controversial Role of Phosphodiesterase Type 5 Inhibitors in the Treatment of Premature Ejaculation

    The Journal of Sexual Medicine

    Volume 8, Issue 8, August 2011, Pages: 2135–2143, Emmanuele A. Jannini, Chris McMahon, Juza Chen, Antonio Aversa and Michael Perelman

    Version of Record online : 26 JUL 2011, DOI: 10.1111/j.1743-6109.2011.02401.x

  16. Subacute Hemolysis in Sickle Cell Mice Causes Priapism Secondary to NO Imbalance and PDE5 Dysregulation

    The Journal of Sexual Medicine

    Volume 12, Issue 9, September 2015, Pages: 1878–1885, Nikolai A. Sopko, Hotaka Matsui, Johanna L. Hannan, Dan Berkowitz, Hunter C. Champion, Lewis L. Hsu, Biljana Musicki, Arthur L. Burnett and Trinity J. Bivalacqua

    Version of Record online : 7 SEP 2015, DOI: 10.1111/jsm.12976

  17. Proceedings of the 16th World Meeting on Sexual Medicine, São Paulo, Brazil, October 8–12, 2014

    The Journal of Sexual Medicine

    Volume 12, Issue S1, January 2015, Pages: 1–96,

    Version of Record online : 22 JAN 2015, DOI: 10.1111/jsm.12826

  18. You have free access to this content
    Prevalence and detection rate of underlying disease in men with erectile dysfunction receiving phosphodiesterase type 5 inhibitors in the United Kingdom: a retrospective database study

    International Journal of Clinical Practice

    Volume 65, Issue 7, July 2011, Pages: 797–806, M. G. Kirby, G. Schnetzler, K.H. Zou and T. Symonds

    Version of Record online : 16 JUN 2011, DOI: 10.1111/j.1742-1241.2011.02693.x

  19. You have free access to this content
    PDE5 inhibitors: considerations for preference and long-term adherence

    International Journal of Clinical Practice

    Volume 67, Issue 8, August 2013, Pages: 768–780, W. B. Smith II, I. R. McCaslin, A. Gokce, S. H. Mandava, L. Trost and W. J. Hellstrom

    Version of Record online : 22 JUL 2013, DOI: 10.1111/ijcp.12074

  20. How to Evaluate the Efficacy of the Phosphodiesterase Type 5 Inhibitors

    The Journal of Sexual Medicine

    Volume 9, Issue 1, January 2012, Pages: 26–33, Emmanuele A. Jannini, Leonard R. DeRogatis, Eric Chung and Gerald B. Brock

    Version of Record online : 4 JAN 2012, DOI: 10.1111/j.1743-6109.2011.02611.x